North America Tracheostomy Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The North America tracheostomy market was valued at US$ 369.38 million in 2023 and is expected to reach US$ 603.40 million by 2031; it is estimated to register a CAGR of 6.3% from 2023 to 2031.

Growing Geriatric Population Fuels North America Tracheostomy Market

Aging leads to reduced lung function and a higher susceptibility to respiratory diseases. The geriatric population is more prone to COPD, pneumonia, asthma, and other respiratory diseases. Majority of the countries across the globe are witnessing an increase in the geriatric population. For instance, according to the US Census Bureau, the number of Americans aged 65 and above is expected to rise from 58 million in 2022 to 82 million by 2050, which is a 47% increase. In addition, the share of the total population for the 65-and-older age group is projected to rise from 17% to 23% by 2050. According to Statistics Canada, in 2022, around one in five Canadians (18.8% of the population; 7,329,910 people) were at least 65 years of age. As per the WHO, by 2030, one in 6 people in the world will be 60 years or older; the number is expected to reach 1.4 billion and 2.1 billion by 2030 and 2050, respectively, from 1 billion in 2020. WHO also stated that by 2050, 80% of older people will be living in low- and middle-income countries. Thus, the increasing geriatric population fuels the growth of the tracheostomy market.

North America Tracheostomy Market Overview

A tracheostomy is a medical surgery in which the airway is directly accessed by creating a hole in the front of the neck into the trachea. It is frequently carried out in situations involving airway obstruction, respiratory failure, trauma, or extended mechanical ventilation. An article in Critical Care Medicine 2020 states that ~100,000 tracheostomies are performed in the US each year.

Government activities aimed at addressing the product shortage are expected to generate growth opportunities for the market in the near future. The U.S. Food and Drug Administration (FDA) informed patients, caregivers, and healthcare providers in October 2022 that there was a shortage of tracheostomy tubes, particularly ICU Medical's Bivona tracheostomy tubes. Pediatric patients were more likely to be affected by a Bivona tracheostomy tube scarcity since there were not as many substitute tubes available with comparable functioning.

North America Tracheostomy Market: Strategic Insights

North America Tracheostomy Market Segmentation Analysis:

The North America tracheostomy market is categorized into type, technique, end user, and country.

Based on types, the North America tracheostomy market is segmented into tracheostomy tubes, tracheostomy ventilation accessories, other accessories, and tracheostomy clean and care kits. The tracheostomy tubes segment held the largest market share in 2023.

In terms of technique, the North America tracheostomy market is bifurcated into surgical tracheostomy and percutaneous dilatational tracheostomy. The percutaneous dilatational tracheostomy segment held a larger market share in 2023.

By hospital type, the North America tracheostomy market is bifurcated hospitals and surgery centers, ambulatory care centers, home care settings, and research laboratories and academic institutes. The hospitals and surgery centers segment held a larger market share in 2023.

By country, the North America tracheostomy market is segmented into the US, Canada, and Mexico. The US dominated the North America tracheostomy market share in 2023.

North America Tracheostomy Market Players Density: Understanding Its Impact on Business Dynamics

The North America Tracheostomy Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Company Profiles

AdvaCare Pharma USA LLC; Andreas Fahl Medizintechnik-Vertrieb GmbH; Angiplast; Boston Medical Products Inc; Coloplast Corp; Cook Medical Holdings LLC; Fisher & Paykel Healthcare Corp Ltd; Fuji Systems Corporation; ICU Medical Inc; Intersurgical Ltd; Kapitex Healthcare Limited; Medtronic Plc; SunMed Group Holdings LLC ( AirLife); Teleflex Inc; Tianjin Medis Medical Device Co. Ltd.; Troge Medical GmbH; VBM Medizintechnik GmbH; and Well Lead Medical Co. Ltd. are among the leading companies operating in the tracheostomy market.